$76.63
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.
Country

US

CEO

Mr. Keith Pfeil

IPO date

2012

Employees

6,000

ISIN

US3795772082

Key stats

Open

$76.63

Volume

2.16M

Market cap

$10.34B

Prev. close

$76.64

Impl / hst vl

-

Open interest

$0.00

$76.63

Day’s Range

$76.63

$74.50

52W Range

$101.40

Valuation

55
Valuation score
Fairly Valued
P/E
18.23
P/S
3.45
P/B
2.26
Current ratio
4.56
Debt / Equity
-0.12
ROE
13.04%
Gross margin
69.20%
Income growth
-11.59%
FCF growth
-21.98

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$110.08
The top 15 analysts forecasts that 12-month price may increase by 43.64%, with a low of $87.87 and a high of $128.10
$87.87
Low
$110.08
Avg
$128.10
High
Current price

Earnings

Q1 ‘26 revenue
$759.85M
Q1 ‘26 net income
$124.30M
Revenue
Net income
Previous EPS
$1.12
Estimate EPS
$1.12
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply